RPS19 and acute kidney injury: A few years later, they further confirmed the protective effects of RPS19 treatment in a mouse model of cisplatin-induced acute kidney injury, showing downregulation of MIF/CD74-induced inflammation, which was similar to results found with MIF knock-out mice [19].